CardioMEMS HF System Real-World Evidence Post-Approval Study

Status Enrolling by invitation

Clinical Trial Summary

The purpose of this post-approval study (PAS) is to evaluate the long-term safety and effectiveness of the CardioMEMS™ HF System using real-world evidence (RWE) methods.

Clinical Trial Description

Subjects will be identified in Abbott's Merlin.net remote monitoring database. Merlin.net data will be linked to Medicare fee-for-service (FFS) claims data to longitudinally track outcomes. Each subject will be followed for a minimum of 36 months. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06306573
Study type	Observational
Source	Abbott Medical Devices
Contact
Status	Enrolling by invitation
Phase
Start date	December 15, 2022
Completion date	December 31, 2028

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04452149` - Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure	N/A
Not yet recruiting	`NCT06097481` - Narrative Intervention for Chronic Illness- Heart Failure Trial (NICI-HF)	Phase 1/Phase 2
Withdrawn	`NCT03005184` - Mechanism(s) Underlying Cardiovascular Effects of ARB/NEP Inhibition - Aim 2	Phase 2
Not yet recruiting	`NCT01669395` - Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial	N/A
Completed	`NCT05835063` - A Study to Improve Physician-Youth Communication and Medical Decision Making	N/A
Completed	`NCT03895073` - HEart fAiluRe evaluaTion Questionnaire
Completed	`NCT03095196` - Multipolar CRT-d and Diabetes	N/A
Recruiting	`NCT03180320` - Baduanjin-eight-silken-movement With Self-efficacy Building for Patients With Chronic Heart Failure (BESMILE-HF Study)	N/A
Completed	`NCT06233695` - Gender-based Differences in the Outcome of Treatment With Aldosterone Antagonists in Patients With Heart Failure
Withdrawn	`NCT03947853` - Clinical Study to Evaluate the Predictive Value of the Heart Failure Questionnaire (HF-Q) for the Occurrence of Μajor Αdverse Cardiovascular Events (MACE) in Patients With Symptomatic Heart Failure
Recruiting	`NCT05934487` - PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III	N/A
Recruiting	`NCT04829617` - Promoting Well-being and Health in Heart Failure	N/A
Recruiting	`NCT03538990` - Effect of DASH Eating Pattern on Heart Failure Outcomes	N/A
Recruiting	`NCT05487365` - Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF	N/A
Completed	`NCT03592836` - Diuretic Response in Advanced Heart Failure: Bolus Intermittent vs Continuous INfusion	Phase 3
Completed	`NCT01560871` - Effects of a Walking Program and Inspiratory Muscle Training in Individuals With Chronic Heart Failure	N/A
Completed	`NCT03387813` - Hemodynamic-GUIDEd Management of Heart Failure	N/A
Not yet recruiting	`NCT06270875` - Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)	N/A
Enrolling by invitation	`NCT05885607` - Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
Active, not recruiting	`NCT04012944` - SIRONA 2 Trial Heart Failure NYHA Class III	N/A